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SllmmAry 
Transgenic expression of interleukin 10 (IL-10) in the islets of Langerhans leads to a pronounced 
pancreatic inflammation, without inflammation of the islets of Langerhans and without diabetes. 
A  scattered infiltration of macrophages (Mtk) precedes localized accumulations of CD4 + and 
CD8 + T lymphocytes, B lymphocytes, and Mtk. This recruitment of inflammatory cells to the 
pancreas is somewhat surprising,  since the biological activities of IL-10 in vitro indicate that 
IL-10 is a powerful immunosuppressive cytokine. Since endothelial cells play a major role in 
leukocyte extravasation, we examined if vascular changes and extralymphoid induction of peripheral 
and mucosal type vascular addressins contributed to IL-lO-induced homing of mononudear cells 
to the pancreas. The endothelium lining small vessds was highly activated in areas of inflammation, 
as  the endothelial cells became cuboidal,  and exhibited increased expression of major histo- 
compatibility complex dass II (Ia), intercellular adhesion molecule 1, and *con WiUebrand Factor. 
Furthermore, induction of vascular addressins simultaneously with accumulation of mononuclear 
cells  around islets  and vessels indicated that  the endothelial cells  take on the phenotype of 
differentiated endothelium specialized  for leukocyte extravasation.  In  conclusion,  pancreatic 
inflammation and vascular changes are prominent in IL-IO transgenic mice. We hypothesize that 
IL-IO, in addition to its immuno-inhibitory properties, is a potent recruitment signal for leukocyte 
migration in vivo.  These effects are relevant for in vivo therapeutic applications of IL-IO. 
I 
L-10 is produced from Th lymphocytes, Lyl + B lympho- 
cytes, and macrophages (Mck)  1 (1-3). IL-10 decreases MO 
production of IL-1, IL-6, TNF-c~, and nitrogen oxide, and 
inhibits IFN-3~ and IL-3 secretion from Thl lymphocytes (1, 
4-6).  IL-10 has not only antiinflammatory properties, but 
stimulates differentiation of mast cells and CTLs (1). Taken 
together, these in vitro studies indicate that IL-10 is a powerfial 
immunosuppressor and,  therefore, may be a potential im- 
munosuppressive compound for treatment of autoimmune 
diseases  and allograft rejections. 
To correlate in vitro observations with in vivo effects, we 
created transgenic mice with localized expression of IL-10. 
Since transgenic expression of IL-10 in pancreatic B cells led 
to homing of inflammatory cells into the exocrine pancreatic 
tissue, the expression of endothelial cell (EC) antigens, an- 
tigens specific for ECs specialized for lymphocyte diapedesis, 
and the expression of adhesion molecules on infiltrating cells 
were examined. 
1 Abbreviations  used in this paper: EC, endothelial  cell; ICAM-1, intercelluhr 
adhesion molecule 1; MO, macrophages;  vWF, yon Willebrand Factor. 
Materials and Methods 
Construction of the ~ansgene  A recombinant phsmid containing 
the human insulin promoter and a terminator sequence from the 
hepatitis B virus gene (7) was cleaved at its unique BamHI site, 
foUowed by blunt-ending  of the site with the Klenow fragment 
of DNA polymerase I. The 594-bp Sad fragment encoding the 
murine Ibl0 was excised from a cDNA done (8), blunt-ended as 
above, and inserted into the BamHI site of the insulin promoter--con- 
taining plasmid. Isolation, purification, and injection of a restric- 
tion fragment of the hybrid DNA molecule were performed as de- 
scribed previously (7). 
Screening of 7~ansgenic Mice.  For Southern blot analysis, 5-10 
/~g of  DNA, extracted from 2-cm-long taft segments, was digested 
with PstI overnight. The DNA was subjected to electrophoresis 
on 0.8% agarose gels and transferred to nitrocellulose membranes 
(NitroPure; Micron Separations Inc., Westboro, MA). Hybridiza- 
tion was performed with radiolabeled restriction fragments of the 
IL-10 cDNA (Prime-It  TM Random Primer Labeling Kit;  Strata- 
gene, La Jolla, CA). Transgenic founders were bred with BALB/c 
mice and killed for histological characterization after transmission 
to one or two litters, as tested by PCR of tail DNA using transgene- 
specific primers. Mice  were maintained in microisolator cages under 
pathogen-free conditions. 
Expression Analysis  by In Situ Hybridization.  Two 3-mo-old IL- 
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Excised pancreata were fixed in 4% paraformaldehyde in PBS for 
10 min, washed in 10, 15, and 20% sucrose, and frozen in Tissue- 
Tek (Miles Laboratories Inc., Elkhart, IN). The RNA probe was 
prepared by in vitro transcription of a linearized phsmid containing 
I1:10 cDNA, using digoxigenin-modified  UTP (Boehringer Mann- 
heim Biochemicals, Indianapolis, IN). In situ hybridization using 
nonisotope-labeled probes was performed as described (9). After 
overnight incubation at 37~  with 50/~1 of probe-containing hy- 
bridization mixture, sections were sequentially reacted with sheep 
anti-digoxigenin antibody (1/~g/ml) (Boehringer Mannheim Bio- 
chemicals), followed by  incubation  with  biotin-labeled  rabbit 
anti-sheep IgG (7.5/~g/ml) (Vector  Laboratories, Inc., Burlingame, 
CA), and horseradish peroxidase (HRP)-labeled avidin-biotin com- 
pl~ (ABC-kit; Vector  Laboratories, Inc.). HRP was visualized  using 
3,3' diaminobenzidine as chromogene. 
Immunohistochemistry.  1- (n =  4), 4- (n = 3), and 6- (n =  2)- 
wk-oldmice, and 2- (n  =  1), 3.5- (n  =  1), 5- (n  =  2), and 
6- (n ~  1) mo-old mice were killed. Mice were obtained from two 
different lines of II,-10 transgenic mice. Normal BALB/c mice or 
negative littermates served as controls. Fresh frozen sections were 
dehydrated in acetone for 5 rain at  -20~  and blocked in 2.0% 
normal goat serum. Infiltrating inflammatory cells were demon- 
strated by reaction with anti-common leukocyte antigen T200 an- 
tibody (5/~g/ml; Boehringer Mannheim Biochemicals). CD4 + Th 
lymphocytes, CD8 § CTL, and B lymphocytes were demonstrated 
by rat anti-mouse L3T4, rat anti-mouse Ly2, and rat anti-mouse 
Ly5 (CD45K/B220),  respectively (all 5/~g/ml; Pharmingen, San 
Diego, CA). Mqb were identified by the F4/80 antibody (culture 
supernatant diluted 1:10; Serotec, Indianapolis, IN). Tissue sped- 
mens were reacted with antibodies against murine LFA-1 and Mac-1 
(both 5/~g/ml; Boehringer Mannheim Biochemicals), and against 
murine r-selectin and lymphocyte peyer's patch high endothelial 
venule adhesion molecules 1 and 2 (LPAM-1 and -2) (R1-2) (7 
/~g/ml; kindly provided by Dr. I. L. Weissman, Stanford Univer- 
sity Medical Center, Stanford, CA). Antibody K1-2 reacts with 
the c~4 chain,  and identifies both LPAM-1 (c~d37) and LPAM-2 
(c~4~1, VLA-4) (10). Expression of vascular addressins were dem- 
onstrated by the antibodies MECA 32, MECA 79, and MECA 
367 (kindly provided by Dr. E. Butcher, Stanford University). Pe- 
ripheral LNs and mucosal lymphoid tissue served as positive con- 
trol organs for the antibodies MECA 79 and 367, respectively.  Fur- 
thermore, sections were stained with antibodies against ICAM-1 
(5/~g/ml; Pharmingen), Ia (5/~g/ml, Boehringer Mannheim Bin- 
chemicals), and vWF (18/~g/ml; Dako Corp., Carpinteria, CA). 
After incubation with biotinylated secondary antibodies, immu- 
nostaining was performed as described above. 
Permeability Studies.  Two  transgenic  mice  and  one normal 
BALB/c mouse were killed 30 min after intravenous injection of 
0.5 g BSA in 500/~1 0.9%  NaC1. The pancreas was isolated, and 
fresh frozen sections  were reacted with a polyclonal  antibody against 
bovine albumin (Sigma Chemical Co., St. Louis, MO) following 
the above protocol. 
Kesuks 
Initial Characterization of lL-lO Transgenic Mi~  Histological 
examination of the transgenic mice demonstrated substantial 
accumulations of inflammatory cells within the exocrine pan- 
creatic tissue in five of nine independent lines of transgenic 
mice. The infiltrates surrounded the islets of Langerhans, 
ranging from a modest peri-islet infiltration in young mice 
(Fig. 1 A) to a profound inflammation of the exocrine tissue, 
in which the acini were replaced by dense sheets of inflam- 
matory cells, necrotic tissue,  and areas of adipose tissue in 
older mice (Fig. 1 B). Although the islets of Langerhans were 
embedded in a sea of leukocytes and necrotic exocrine tissue, 
they remained circumscribed and entirely intact, and the mice 
never became diabetic. Furthermore, the organization of the 
endocrine cells showed the normal mantle of glucagon- and 
somatostatin-containing cells surrounding a core of insulin- 
containing ~  cells (data not shown). The islet-specific  ex- 
pression of the transgene was demonstrated by in situ hy- 
bridization (Fig. 2). No hybridization was found in the pan- 
creas  of control mice. 
Investigation of the chronology of the pancreatic inflam- 
mation indicated that mononuclear cells began to infiltrate 
the pancreas of 1-wk-old transgenic mice. At this age the 
majority of the infiltrating cells were identified as M~ by 
the F4/80 antibody. Focal accumulations of mononuclear cells 
around vessels and islets  were demonstrated at 4-6 wk of 
age, increasing at 2-3 mo of age. At 2 mo of age lympho- 
cytes dominated the inflammation, whereas ,v30%  of the 
infiltrating  cells  were identified  as  macrophages.  Of the 
infiltrating lymphocytes, "~40  and 30%  were CD4 §  and 
CD8 + T lymphocytes, respectively, and "~30% were B lym- 
phocytes (Fig. 3, A-C). A subpopulation of the lymphocytes 
expressed the Lyl antigen. The proportion of different lym- 
phocyte subsets was similar at 6 mo of age. 
As evaluated by bromodeoxyuridine incorporation in vivo, 
the mitotic activity of the extravasated lymphocytes was very 
low (D. Gu, unpublished observation), implying that IL-10- 
induced homing of leukocytes, rather than proliferation of 
inflammatory cells within the pancreas, was responsible for 
the observed lesions.  Since the vessels were very prominent 
in the pancreatic tissue of IL-10 transgenic mice, and since 
leukocyte extravasation is controlled by a specific interaction 
between leukocyte adhesion molecules and the endothelium 
lining the vascular wall, we looked for the presence of en- 
dothelial changes, the possible expression of vascuhr addressing 
and the expression of different adhesion molecules in the pan- 
creatic inflammation. 
Characterization  of the  Endothelium  in  IL-IO  Transgenic 
M/cp  The antibody MECA 32 recognizes an antigen present 
on all  types of endothelium,  and was  therefore used for 
identification and structural characterization of ECs. In pan- 
creata from 1-wk-old transgenic mice the MECA 32-positive 
vessels had a larger outer diameter than the MECA 32-reacting 
vessels in negative littermates, and they appeared more fre- 
quently (Fig.  4, A  and B). In older transgenic mice (>6-8 
wk) structural changes in small vessels were demonstrated 
in areas ofinfhmmation only (Fig. 4 C). ECs lining the small 
vessels were plump and cuboidal, and demonstrated increased 
staining intensity (Fig.  4 D) when compared with the ECs 
lining small vessels in noninflammatory areas of the same pan- 
creas (Fig.  4 E) or with negative littermates. 
Unstimulated endothelium has low expression of intercel- 
lular adhesion molecule 1 (ICAM-1) and MHC class II an- 
tigens (11). However, the expression of ICAM-1 and Ia in- 
creases  in  inflammatory  loci.  Furthermore,  exposure  to 
176  Interleukin  10 Promotes Leukocyte  Homing In Vivo Figure  1.  Hematoxylin and eosin staining of pancreatic tissue from mice expressing IL-10 in the pancreatic ~3 cells. In early stages of inflammation 
infiltrating  cells have a peri-vascular or peri-islet localization (A) (x80). In later stages a profound inflammation involves most of the pancreatic tissue, 
leaving  the islets of Langerhans  intact  (B) (x40).  (b) Islet of Langerhans. 
cytokines potentiates histamine- and  thrombin-stimulated 
secretion of yon Willebrand Factor (vWF), and increased secre- 
tion and leakage of vWF into adjacent tissue is demonstrated 
in inflamed loci (12, 13). Pancreatic  tissue from the trans- 
genic mice was subjected to antibodies against ICAM-1, Ia, 
and vWF to determine if the pancreatic endothelium in the 
transgenic mice showed any functional changes. In pancreata 
of 1-wk-old transgenic mice, vessels expressing ICAM-1 and 
Ia appeared more frequently than in nontransgenic littermates 
(Fig.  5, A  and B). Expression of ICAM-1 and Ia increased 
progressively on the surface of the ECs lining small arteries, 
venules, pancreatic ducts, and interacinar capillaries in mice 
from 4 wk to 2 mo of age (Fig. 5, C and D). Cells expressing 
ICAM-1 and Ia were also demonstrated in the islets of Lan- 
gerhans. However, expression seemed to be localized to the 
capillaries and not to the endocrine cells. In pancreata from 
1-wk-old normal mice only a few vessels showed expression 
of vWF (Fig.  6 A), whereas small vWF-expressing vessels 
appeared throughout the pancreas in age-matched transgenic 
mice (Fig. 6 B). In pancreatic tissue from normal adult mice, 
vWF staining had a granular appearance and was expressed 
on the luminal edge of scattered  larger arteries  and venules 
(Fig. 6 C). As described for rats (14), some islets of Langer- 
hans could easily be identified by a characteristic  expression 
of vWF (Fig. 6 C). Distant from inflammatory loci, the ex- 
pression of vWF in pancreata  from transgenic mice >4 wk 
of age was similar to normal controls, whereas small, vWF- 
positive vessels appeared in the infiltrates,  including small 
vessels lined by high ECs (Fig. 6 D). Expression of vWF was 
induced on interacinar capillaries diverging out from inflam- 
matory loci, and vWF was seen leaking out into the sur- 
rounding parenchyma. Pancreatic ducts embedded in inflam- 
matory cells did not express vWF (Fig.  6 D). 
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During stimulation of ECs with cytokines the vascular per- 
meability increases (15). Therefore, we tested the permeability 
for albumin of the pancreatic vessels. After injection of BSA, 
reaction of the pancreatic tissue with an albumin antibody 
demonstrated  extravascular  accumulations  of albumin  in 
inflammatory loci only (Fig. 6 E). No albumin deposits were 
detectable in the pancreatic tissue from untreated transgenic 
mice. We could not demonstrate sediments of albumin in 
the pancreas of a normal BALB/c mouse after injection of BSA. 
Figure  2.  Demonstration of IL-10 expression in islets of Langerhans 
by in situ  hybridization.  Hybridization with digoxigenin-labeled  probe 
shows islet-specific expression of IL-10. Figure 3.  Lymphocyte subsets in a peri-islet infiltrate in Ib-10 trans- 
genic mice. To identify lymphocyte subsets in the peri-islet infiltrations, 
pancreatic sections from a 2-mo-old 1I.-10 transgenic mouse were reacted 
with Ly5 (CD45R/B220), L3T4, and Ly2 antibodies for detection of B 
lymphocytes  (,4),  CD4 +  Th lymphocytes  (B), and CD8 +  CTL (C), 
respectively (all  x 72). (b) Islet of hngerhans. 
In summary, our observations indicate that ECs are highly 
activated,  and have increased adhesion properties, l~urther  - 
more, the increased permeability may contribute to spreading 
of the inflammatory process. 
Expression of Vascular Addressins in IL-IO  Transgenic Mice 
Leukocytes  may not only pass through stimulated endothelium 
but also through tissue-specific postcapillary high endothelial 
venules (HEV), specialized for lymphocyte diapedesis (16). 
The two best characterized  types of HEV are HEV in pe- 
ripheral LN, identified by the mAb MECA 79 (17) recog- 
nizing the peripheral LN vascular addressin (PNAd) (18), and 
HEV in mucosal lymphoid tissue (Peyer's patches and ap- 
pendix), defined by the mAb MECA 367 (19) recognizing 
the mucosal vascular addressin (MAd) (20). Expression of pe- 
ripheral and mucosal HEV in nonlymphoid  organs is described 
in areas of chronic inflammation, contributing to homing 
of inflammatory ceUs in peripheral tissues  (21-23).  To ex- 
amine if induction of extralymphoid HEV could be a factor 
responsible  for homing and extravasation  of inflammatory 
ceils to the pancreas in IL-10 transgenic mice, pancreatic tissue 
was reacted with the antibodies MECA 367 and MECA 79. 
The antigen specific for HEV in Peyer's Patches, defined by 
MECA 367,  was expressed in a scattered  manner both in 
1-wk-old normal and transgenic mice. Small vessels reactive 
with the MECA 367 antibody were induced in areas of inflam- 
mation (Fig. 7 A), even when only very few inflammatory 
cells were accumulating  around vessds and islets. The number 
of small vessels expressing this antigen increased  with the 
severity of the surrounding  inflammation. The antigen specific 
for HEV in peripheral lymph nodes, identified by MECA 
79, was not expressed in pancreatic tissue from young or adult 
normal mice. This antigen was expressed in sinai1 vessds in 
the inflammatory infiltrates  in transgenic mice >3.5 mo of 
age only (Fig. 7 B). The findings indicate that leukocyte ex- 
travasation in the present model of pancreatic inflammation 
may take place  not only through activated  ECs, but also 
through differentiated ECs with phenotypical characteristics 
of mucosal HEV and peripheral type HEV. 
Expression of Leukocyte Adhesion Molecules in IL-IO  Trans- 
genic Mice.  Since the ligand for L-sdectin is expressed on 
peripheral LN HEV (24) and on activated endothelium (25), 
we tested the expression of this leukocyte adhesion molecule 
on the infiltrating cells. In mice >4 wk of age L-selectin- 
expressing mononudear  ceils were demonstrated  around vessels 
and islets of Langerhans (Fig. 8 A). The presence of L-sdectin- 
expressing leukocytes suggests that an interaction between 
these cells and ligands on induced peripheral-type HEV may 
take place. 
Because the integrin ICAM-1 is hyperoqnmsed  in our trans- 
genic mice, and the ECs express antigens characteristic  for 
mucosal HEV, we tested if infiltrating cells expressed  the 
respective integrin ligands, such as Mac-1/LFA-1 and LPAM- 
1/LPAM-2,  respectively  (10). At  1 and 4  wk of age,  the 
diffusely infiltrating F4/80 cells predictably expressed Mac-1 
and LFA-1, although the latter in smaller amounts (Fig. 8, 
B and C). Also, at 4-6 wk of age, when localized accumula- 
tion of F4/80 ceUs was evident, the ceils expressed Mac-1 
and LFA-1 (Fig.  8,  D  and E).  Approximately 30-40%  of 
178  Interleukin 10 Promotes Leukocyte Homing In Vivo Figure  4.  Pancreatic expression of a pan-endothelial marker, as defined 
by the antibody MECA 32. Pancreatic tissue from a 1-wk-old nontrans- 
genic mouse (,4) and from an age-matched littermate e~pressing Ibl0 in 
islets of Langerhans (B) (both x160). (C) Pancreatic tissue from an 8-wk- 
old IL-10 rransgenic mouse demonstrating an increased number of small 
vessels expressing the EC marker in areas of inflammation (arrowheads) 
(xSO).  ECs in small vessels in inflammatory loci become thick and cu- 
boidal (D) as compared with ECs in noninflammatory loci (E) (both x400). 
(a) duct;  (b) islet of Langerhans;  (c) vessels. 
179  Wogensen et al. Figure  5.  Pancreatic ~pression of ICAM-1 and Ia. Pancreatic tissue from a 1-wk-old nontransgenic mouse (A) and from an age-matched littermate 
expressing  ILl0 in the islets of Langerhans  (/3) reacted with an anti-ICAM-1 antibody (both  xS0). ICAM-1 (C) (x40) and Ia (D) (x80) expression 
in pancreatic tissue  from an 8-wk-old Ibl0 transgenic mouse.  (a) duct;  (b) islet of Langerhans;  (c) vessels. 
the  infiltrating  cells  expressed  the  c~4  integrin  chain  of 
LPAM-1 and -2 in all tested mice and followed the same pat- 
tern of infiltration as described above (data not shown). The 
observations support the notion that extravasation of inflam- 
matory cells in the present model of pancreatic inflammation 
in part is mediated by interaction between upregulated en- 
dothelial adhesion molecules and vascular addressins, and their 
respective leukocytic ligands. 
For the understanding of the pathogenetic mechanisms in 
IL-10-induced inflammation, it was interesting to test if the 
infiltrating leukocytes exhibited high levels of ICAM-1 ex- 
pression.  However, in the pancreata of 1-wk-old transgenic 
mice, only diffusely scattered cells were ICAM-1 positive (Hg. 
5 A). In older mice some of the infiltrating calls, located in 
the periphery of the inflammatory loci, expressed ICAM-1 
on the call surface, although a rather large number of cells 
did not show detectable expression of this adhesion molecule 
(rig.  5 63. 
Discussion 
Transgenic expression of IL-10 in the islets of Langerhans 
leads to a pronounced pancreatic inflammation dominated 
by CD4 + and CD8 + T  and B lymphocytes. The islets of 
Langerhans remain entirely intact, and the transgenic mice 
do not develop diabetes. The observation contrasts, at least 
superficially, the reported in vitro activities  of human and 
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of vWF and demonstration  of in- 
creased  permeability.  The expression 
pattern of  vWF in pancreatic  tissue 
from a 1-wk-old normal (A) and 
from a 1-wk-old I1r  transgenic 
mouse (B) (both x60). The latter 
shows an increase  in the number  of 
small  vessels  expressing  vWF.  vWF 
expression  in an islet  of  Langerhans 
in  an  adult normal mouse (C-') 
(x60).  Demonstration of  pro- 
nounced vWF  staining in larger 
vessels,  and the appearance  of  smaller 
vessels expressing  vWF in inflamed 
loci (/9) (arrowheads)  (x30). For the 
demonstration  of  increased  vascuhr 
permeability  transgenic  mice  were 
injected intravenously  with 0.5 g 
BSA. After 30 min the mice were 
killed, and  the  pancreases were 
processed for immunohistochem- 
istry. The presence of albumin in 
inflamed  loci  indicates  an increased 
vascular  permeability  (E) (x 120). (a) 
duct; (b)  islet of Langerhans; (c) 
vessels. 
murine IL-10, which indicate that IL-10 is a powerful im- 
munosuppressor (1). The chronological appearance of  leuko- 
cyte subsets and the pattern of migration in IL-10 transgenic 
mice is similar to what is demonstrated in several  animal models 
of insulin dependent diabetes mellitus (IDDM) (26-28) and 
in transgenic mice expressing IFN-3' in the pancreatic ~/cells 
(M.-S. Lee, personal communication), although the rapidity 
of the process  may differ.  This implies the existence  of a 
common migration pattern, irrespective  of the initial lesion 
resulting in pancreatic infiltration. Very puzzling, and in con- 
trast to animal models of IDDM- and IFN-~-expressing mice 
(7), lymphocyte  penetration into islets and subsequent ~/cell 
181  Wogensen  et al. 
destruction are entirely absent in IL-10 transgenic mice. The 
mechanism of B cell  killing in IFN-y transgenic mice is 
thought to occur by IFN-3,-induced activation of quiescent 
autoreactive lymphocytes in vivo (29).  In contrast, the ab- 
sence of ~ cell destruction in IL-IO transgenic mice may be 
explained  by  IL-10-induced  inhibition  of  the  antigen- 
presenting capacity of M~, inhibition of antigen-specific  T 
cell proliferation, and reduced cytokine production; conse- 
quently, the/5 cells are not exposed to cytotoxic cytokines 
and antigen sensitization is prevented. However, the lack of 
insulitis in the IL-IO transgenic mice could reflect differences 
in the expression  pattern of appropriate adhesion molecules Figure  7.  Pancreatic expression of vascular addressins. Expression of the mucosal (arrowheads) (/1) and the peripheral LN (arrowheads) (,8) vascular 
addressins in Ibl0 transgenic mice, identified by the antibodies MECA 367 and MECA 79, respectively (both  x80). (a) duct; (b) islet of Langerhans. 
on the islet vasculature, inhibiting 13 cell exposure to the im- 
mune system. 
Since murine IL-10 enhances the growth factor-induced 
proliferation of mature CD4 + and CD8 + T  lymphocytes 
(30),  and enhances the differentiation of cytotoxic T  cell 
precursors into CD8 + cytotoxic T cells (31), local prolifera- 
tion of lymphocytes could in part explain the accumulation 
of inflammatory cells in the pancreas. However,  the mitotic 
activity of the extravasated lymphocytes was very low.  To 
elucidate the role of the endothelial cells in IL-10-induced 
leukocyte extravasation,  we examined the pancreas for vas- 
cular changes. The functional and structural changes of the 
endothelium, such as increased expression  of ICAM-1, Ia, 
and vWF, increased permeability, neoexpression of vascular 
addressins, and appearance of small vessels  with cuboidal ECs, 
indicate that the ECs are highly activated  (11-13) and take 
on the phenotype of differentiated  endothelium specialized 
for leukocyte extravasation  (16, 32).  The leukocyte ligands 
for ICAM-1 (Mac-1 and LFA-1), Mad (LPAM-1/2), and PNad 
(t-selectin) were expressed on a majority of the infiltrating 
cells mediating adhesion to the activated  endothelium and 
neo-expressed  vascular addressins. Therefore, our data sug- 
gest that IL-10 is a potent signal for leukocyte extravasation 
in vivo. 
Expression of MHC class I and II, and ICAM-1 on ECs, 
are influenced by cytokines at sites of inflammation (33-38). 
Furthermore, cytokines, particularly IFN-3,, are decisive for 
the maintenance and "adhesiveness"  of peripheral LN and 
mucosal HEV  (39-42).  This indicates  that  normal "flat" 
endothelium may differentiate into endothelium with HEV 
characteristics by exposure to IFN-3, and other cytokines in 
inflammatory loci, e.g., in arthritis, experimental allergic en- 
cephalomyelitis (21, 23, 43), or as reported herein. Since we 
did not find any evidence of vasculogenesis, indicated by the 
absence of mitotic activity in small vessels, it is most likely 
that preexisting vessels develop phenotypic characteristics of 
HEV.  In IL-10 transgenic mice the initial observation was 
stimulation of the ECs, indicated by increased expression of 
ICAM-1, Ia, and vWF, and homing of Mac-l-positive cells 
to the pancreas. Preliminary studies show that IL-10 induces 
ICAM-1  expression  on ECs  in  vitro.  Therefore,  vascular 
changes in vivo may, at least partly, be mediated directly by 
IL-10, although the Thl cell production of granulocyte-M<k/ 
monocyte-CSF (GM-CSF), lymphotoxin (LT), and TNF-oL, 
which is not downregulated by IL-10  (44),  and thrombin 
and histamine, produced from the inf~trating cells, most likely 
plays a major role in the differentiation of the ECs. 
In conclusion, transgenic expression of IL-10 in pancreatic 
15 cell leads to a pronounced  pancreatic inflammation. Homing 
of target cells to the location of IL-10 production may be 
important for the manifestation of the immunosuppressive 
function on otherwise distant,  circulating leukocytes.  We 
hypothesize that IL-10, in addition to its in vitro immunoin- 
hibitory properties, can attract leukocytes in vivo. These results 
may have important consequences on the therapeutic use of 
IL-10. 
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cyte adhesion molecules in  IL-10 
transgenic mice. To  identify the 
presence of  different leukocyte  adhe- 
sion molecules, pancreatic tissue was 
reacted with antibodies recognizing 
L-selectin (A) (x 120), Mac-1 (/3 and 
D), and LFA-1 (C and E). Mac-I- 
positive  ceils were scattered in l-wk- 
old mice (B) (x 120), but showed a 
localized  distribution  in  older 
animals (D) (x 120). A similar pat- 
tern was demonstrated  for LFA-1  ~x- 
pression in young (C) (x120) and 
older mice (E) (x120). (b) Islet of 
Langerhans. 
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